Trial Details
Not recruitingBasic Information
| Clinical ID | c3236 |
|---|---|
| Identifier | NCT01352221 |
| Trial Title | A Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study With Oral ST10-021 for the Treatment of Iron Deficiency Anaemia in Subjects With Quiescent Crohn's Disease Where Oral Ferrous Preparations Have Failed or Cannot be Used (AEGIS 2) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Iron Deficiency Anaemia;Inflammatory Bowel Disease;Crohn's Disease |
| Interventions | Drug: ST10;Drug: Placebo oral capsule |
Participant Information
| Sponsor | Shield Therapeutics |
|---|---|
| City | - |
| Country/Region | Austria;United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | 2017-10-27 |
| Completion Date | - |